alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.2**

**CERTIFICATION OF PERIODIC REPORT**

I, Stacey L. Moran, Executive Vice President & ChiefFinancial Officer of Suffolk Bancorp (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that: (1) the Quarterly Report on Form 10-Q of the Company for the quarterlyperiod ended June 30, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and (2) the information contained in the Reportfairly represents, in all material respects, the financial condition and results of operations of the Company. 

Dated: August 4, 2009 

/s/ Stacey L. Moran 

Stacey L. Moran 

Executive Vice President & Chief Financial Officer
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   6-M0S
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   JUN-30-1997
<CASH>                                         159,292
<SECURITIES>                                   0
<RECEIVABLES>                                  404,093
<ALLOWANCES>                                   (56,591)
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         5,726,238
<DEPRECIATION>                                 (2,044,440)
<TOTAL-ASSETS>                                 4,990,138
<CURRENT-LIABILITIES>                          0
<BONDS>                                        4,491,805
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     298,530
<TOTAL-LIABILITY-AND-EQUITY>                   4,990,138
<SALES>                                        892,250
<TOTAL-REVENUES>                               1,359,774
<CGS>                                          0
<TOTAL-COSTS>                                  812,881
<OTHER-EXPENSES>                               305,161
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             241,728
<INCOME-PRETAX>                                4
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            4
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   4
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
<FN>
               NOTE:  TOTAL CURRENT ASSETSA AND CURRENT LIABILITIES ARE NOT
                      APPLICABLE BECAUSE REGISTRANT DOES NOT PRESENT A 
                      CLASSIFIED BALANCE SHEET.
</FN>

        


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

          - [License No. 09/79-0453]

Notice is hereby given that Telegraph Hill Partners SBIC, L.P., 360 Post Street, Suite 601, San Francisco, CA 94108, a Federal Licensee under the Small Business Investment Act of 1958, as amended (“the Act”), in connection with the financing of a small concern, has sought an exemption under Section 312 of the Act and Section 107.730, Financings which Constitute Conflicts of Interest of the Small Business Administration (“SBA”) Rules and Regulations (13 CFR 107.730). Telegraph Hill Partners SBIC, L.P. proposes to provide equity security financing to Althea Technologies, Inc., 11040 Roselle Street, San Diego, CA 92121. The financing is contemplated for working capital and general corporate purposes.

The financing is brought within the purview of section 107.730(a)(1) of the Regulations because Telegraph Hill Partners II, L.P., THP II Affiliates Fund, L.P., and THP Affiliates Fund, L.P., all Associates of Telegraph Hill Partners SBIC, L.P., own more than ten percent of Althea Technologies, Inc.

Therefore, this transaction is considered a financing of an Associate requiring an exemption. Notice is hereby given that any interested person may submit written comments on the transaction within fifteen days of the date of this publication to the Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street, SW., Washington, DC 20416.

Dated: February 19, 2009.

Harry Haskins,

Acting Associate Administrator for Investment.

[FR Doc. E9-8794 Filed 4-16-09; 8:45 am]

BILLING CODE 8025-01-P
Exhibit 24.1

POWER OF ATTORNEY

| |  | GTA-IB, LLC
| |  | -----------
| |  | By:        

Each
of the undersigned officers and managers of GTA-IB, LLC. does hereby constitute and appoint W. Bradley Blair, II and Scott D. Peters, and each of them individually, his
true and lawful attorneys-in-fact and agents, each with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all
capacities, to sign any and all amendments to this report, and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in
and about the premises, as fully to all intents and purposes as he might or could do in person, hereby, ratifying and confirming all that each of said attorneys-in-fact and
agents, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons in the capacities and on the dates indicated:

|Signature                                   |  | Title                                                                                                         |  | Date          
|------------------------------------------- |  | ------------------------------------------------------------------------------------------------------------- |  | --------------
|                                            |  |                                                                                                               |  |               
|/s/W. BRADLEY BLAIR, IIW. Bradley Blair, II |  | Chief Executive Officer and Manager (Principal Executive Officer)                                             |  | March 31, 2005
|/s/SCOTT D. PETERSScott D. Peters           |  | Chief Financial Officer, Secretary and Manager (Principal Financial Officer and Principal Accounting Officer) |  | March 31, 2005
|/s/RAYMOND V. JONESRaymond V. Jones         |  | Manager                                                                                                       |  | March 31, 2005
|/s/FRED W. REAMSFred W. Reams               |  | Manager                                                                                                       |  | March 31, 2005
|/s/EDWARD L. WAXEdward L. Wax               |  | Manager                                                                                                       |  | March 31, 2005

---



QuickLinks
CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

      The undersigned hereby certify,  pursuant to 18 U.S.C.  Section 906 of the
Sarbanes-Oxley  Act of 2002,  that,  to the  undersigned's  best  knowledge  and
belief,  the  Quarterly  Report  on Form  10-Q for the Dyco Oil and Gas  Program
1985-1  Limited  Partnership  ("Issuer")  for the period ending June 30, 2002 as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"):

      (a)   fully complies with the  requirements of section 13(a) or 15(d) of
            the Securities Exchange Act of 1934; and
      (b)   the  information  contained in the Report  fairly  presents,  in all
            material respects, the financial condition and results of operations
            of the Issuer.

      Dated this 5th day of August, 2002.

                                    DYCO OIL AND GAS PROGRAM 1985-1
                                    LIMITED PARTNERSHIP
                                   ("Issuer")

                                    //s// Dennis R. Neill
                                    ------------------------------
                                    Dennis R. Neill
                                    President (Chief Executive Officer)

                                    //s//Craig D. Loseke
                                    ------------------------------
                                    Craig D. Loseke
                                    Chief Financial Officer
CONSENT OF INDEPENDENT AUDITOR

We have issued our report dated March 31, 2008, accompanying the
consolidated financial statements in the Annual Report of
Pricester.com, Inc. on Form 10-KSB/A for the year ended December 31,
2007.  We hereby consent to the incorporation by reference of said
report in the Registration Statements of Pricester.com, Inc. on Form S-
8 (File No. 33-148629, File No. 333-144042, File No. 333-144041, File
No. 333-142240 and File No.333-140036).

/s/Baum & Company, PA
Coral Springs, FL
April 18, 2008
---

Exhibit 32.a


CERTIFICATION PURSUANT TO 
    18 U.S.C. SECTION 1350 
    AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Company’s Report of Dynamic Gold Corp. (the "Company") on Form 10-K for the year ended June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Tim Coupland, Principal Executive Officer and I, Robert Hall, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1)
      The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)
      The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. / s / Tim CouplandTim Coupland, Principal Executive Officer 
    September 17, 2013 / s / Robert HallRobert Hall, Principal Financial Officer 
    September 17, 2013


---
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2865 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2865

  To suspend temporarily the duty on bis (2,3-dibromopropyl ether) of 
                         Tetrabromobisphenol A.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

   Mr. Pryor introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To suspend temporarily the duty on bis (2,3-dibromopropyl ether) of 
                         Tetrabromobisphenol A.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BIS (2,3-DIBROMOPROPYL ETHER) OF TETRABROMOBISPHENOL A.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Bis (2,3-           Free         No change        No change        On or before 12/  ''.
                        dibromopropyl                                                      31/2015.......
                        ether) of
                        Tetrabromobisphen
                        ol A (CAS No.
                        21850-44-2)
                        (provided for in
                        subheading
                        2909.50.50)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             270
<SECURITIES>                                         0
<RECEIVABLES>                                    2,997
<ALLOWANCES>                                         0
<INVENTORY>                                      2,234
<CURRENT-ASSETS>                                 5,533
<PP&E>                                           4,262
<DEPRECIATION>                                   3,608
<TOTAL-ASSETS>                                   8,531
<CURRENT-LIABILITIES>                            3,673
<BONDS>                                          1,377
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      1,250
<COMMON>                                         2,189
<OTHER-SE>                                          42
<TOTAL-LIABILITY-AND-EQUITY>                     8,531
<SALES>                                            365
<TOTAL-REVENUES>                                 3,610
<CGS>                                               45
<TOTAL-COSTS>                                    2,698
<OTHER-EXPENSES>                                 1,472
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  32
<INCOME-PRETAX>                                  (592)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (592)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (592)
<EPS-BASIC>                                     (0.07)
<EPS-DILUTED>                                   (0.07)


</TABLE>
Exhibit 10.27


 


2008
Base Salaries for Named Executive Officers


 


	
  Name and Title

  	
   

  	
  Salary

  	
   

  
	
  James M. Gower

  	
   

  	
  $

  	
  600,000

  	
   

  
	
  Chief Executive
  Officer

  	
   

  	
   

  	
   

  
	
  Ryan D. Maynard

  	
   

  	
  $

  	
  300,000

  	
   

  
	
  Chief Financial
  Officer and Vice President

  	
   

  	
   

  	
   

  
	
  Donald G. Payan

  	
   

  	
  $

  	
  483,000

  	
   

  
	
  Executive Vice
  President, President of Discovery and Research

  	
   

  	
   

  	
   

  
	
  Elliot B.
  Grossbard

  	
   

  	
  $

  	
  450,200

  	
   

  
	
  Executive Vice
  President, Chief Medical Officer

  	
   

  	
   

  	
   

  
	
  Raul R.
  Rodriguez

  	
   

  	
  $

  	
  430,000

  	
   

  
	
  Executive Vice
  President, Chief Operating Officer
Raleigh BROADNAX, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-576

District Court of Appeal of Florida, Second District.

January 3, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
AFS-13-498-E

August 29, 2013

 Exemption No. 10860

 Regulatory Docket No. FAA-2013-0728

Mr. Jordan Pulaski

Parent of Sarah Pulaski

18304 Leedstown Way

Olney, MD 20832

Dear Mr. Pulaski:

This letter is to inform you that we have granted your request for exemption. It transmits our 

decision, explains its basis, and lists the conditions and limitations of the exemption, 

including the date it ends.

The Basis for Our Decision

By letter received August 8, 2013, you petitioned the Federal Aviation Administration (FAA) 

on behalf of Sarah Pulaski for an exemption from § 121.311(b)(2)(iii)(B) of Title 14, Code of 

Federal Regulations (14 CFR). That exemption, if granted, would allow Sarah to exceed the 

specified weight limit for an FAA-approved child restraint system (CAReS, manufactured by 

AmSafe Corporation) during use of that child restraint system (CRS) aboard a United States 

(U.S.) aircraft.

The FAA has determined that good cause exists for not publishing a summary of the petition 

in the Federal Register because the requested exemption would not set a precedent and any 

delay in acting on this petition would be detrimental to Sarah.

The FAA has issued grants of exemption in circumstances similar in all material respects to 

those presented in your petition. In Grant of Exemption No. 9834 (copy enclosed), the FAA 

found that numerous people with physical challenges had previously completed flights using 

restraint systems that addressed unique physical needs regarding safety, support, and security 

in the same manner of operations as described in this petition. The FAA further found that the 
2

petition, if granted, would not set any new precedents regarding the use of restraint systems by 

persons with disabilities.

Having reviewed your reasons for requesting an exemption, I find that—

• they do not differ materially from those presented by the petitioner in the enclosed grant.

• the reasons stated by the FAA for granting the enclosed exemption also apply to the 

situation you present; and 

• a grant of exemption is in the public interest.

Our Decision

Under the authority contained in 49 U.S.C. 40113 and 44701, which the FAA Administrator 

has delegated to me, I hereby grant Sarah Pulaski an exemption from § 121.311(b). In 

addition, any air carrier or commercial operator operating under part 121 while Sarah is

aboard its aircraft is granted an exemption from 14 CFR § 121.311(b) to the extent necessary 

to allow her to use an FAA-approved CRS aboard a U.S. aircraft.

All operations under this exemption must be conducted with at least one of Sarah’s parents or 

a caregiver accompanying her. Sarah Pulaski may only occupy a passenger seat with no 

passenger seated behind her. In addition, Sarah’s parent or caregiver must carry a copy of this 

exemption and advise the air carrier about the contents of the exemption at least 48 hours 

before the date of each flight.

This exemption terminates on September 30, 2018, unless sooner superseded or rescinded.

Sincerely,

/s/

Michael J. Zenkovich

Deputy Director, Flight Standards Service

Enclosure
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2929 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2929

              To suspend temporarily the duty on hirvenal.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
              To suspend temporarily the duty on hirvenal.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. HIRVENAL.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      2,3-Dihydro-1,1-    Free         No change        No change        On or before 12/  ''.
                        dimethyl-1H-                                                       31/2015.......
                        indene-ar-
                        propanal
                        (hirvenal) (CAS
                        No. 300371-33-9)
                        (provided for in
                        subheading
                        2912.19.20)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
aex1041modificationofcon






Jill M. Leitl Chief Operating Officer 01/06/2022 Wesley Beemer Digitally signed by Wesley  Beemer  Date: 2022.01.07 08:05:44  -05'00'
EXHIBIT 99.1

                                  CERTIFICATION

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 and accompanies the quarterly  report on Form 10-Q (the "Form 10-Q") for
the quarter ended September 30, 2002 of American  Insured  Mortgage  Investors -
Series 85, L.P. (the "Issuer").

I,   William B. Dockser, certify that to the best of my knowledge:

     (i)  the Form 10-Q fully complies with the requirements of section 13(a) or
          section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a)
          or 78o(d)); and

     (ii) the information  contained in the Form 10-Q fairly represents,  in all
          material respects,  the financial  condition and results of operations
          of the Issuer.


                                                     AMERICAN INSURED MORTGAGE
                                                     INVESTORS - SERIES 85, L.P.
                                                     (Registrant)

                                                     By: CRIIMI, Inc.
                                                         General Partner



November 14, 2002                                    /s/ William B. Dockser
-----------------                                    ----------------------
Date                                                 William B. Dockser
                                                     Chairman of the Board  and
                                                     Chief Executive Officer